Association Between Schizophrenia and Subsequent Cancer Diagnoses: A Retrospective Cohort Study From Germany

Author(s)

Rastert I1, Vetter C2, Kostev K3
1IQVIA, München, Germany, 2IQVIA Commercial GmbH & Co. OHG, Frankfurt am Main, HE, Germany, 3IQVIA Commercial GmbH & Co. OHG, Franfurt am Main, HE, Germany

OBJECTIVES: As previous studies have reported contradictory findings regarding the relationship between schizophrenia and cancer, we evaluated the association between schizophrenia and cancer diagnoses.

METHODS: In this retrospective cohort study, the IQVIA Disease Analyzer database was utilized to examine the incidence of cancer among patients aged over 18 years diagnosed with schizophrenia in German general practices from 2005 to 2022. Patients with schizophrenia were compared with those without the condition, with adjustments made for age, sex, index year of diagnosis, average annual practitioners visit frequency, and comorbidity. Kaplan-Meier curves were used to analyze the 10-year cumulative incidence of schizophrenia and cancer in total amongst patients with and without schizophrenia. Univariable Cox regression analysis was performed to calculate Hazard Ratios (HR) of cancer risk and their 95% confidence intervals (CI) of cancer in total and of specific cancer types.

RESULTS: Patients with schizophrenia (N=13.711) had a lower risk of cancer diagnosis compared to those without (N=68.555). Specifically, 10.4% of patients with schizophrenia and 12.5% of patients without the condition were diagnosed with cancer (p<0.001). Cox regression analysis showed a significant association between schizophrenia and subsequent cancer in the total population (HR: 0.82; 95% CI: 0.76-0.90), and among men (HR: 0.70; 95% CI: 0.61-0.80), but not among women (HR: 0.94, 95% CI: 0.84-1.04). Analyses stratified by cancer type and sex revealed a strong and significant association between schizophrenia and a decreased risk of prostate cancer in men (HR: 0.38; 95% CI: 0.24-0.61). Furthermore, there was also a negative association between schizophrenia and colorectal cancer risk, but statistical significance was not reached (HR: 0.58; 95% CI: 0.37-0.93).

CONCLUSIONS: This study demonstrates negative associations between schizophrenia and subsequent cancer, and more specifically in men for prostate and colorectal cancer. However, further research is required to explore the underlying reasons for these associations.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

EPH85

Topic

Clinical Outcomes, Epidemiology & Public Health, Study Approaches

Topic Subcategory

Clinician Reported Outcomes, Electronic Medical & Health Records

Disease

Mental Health (including addition), Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×